Good Health is Your Greatest Wealth……Virgil
NEW DELHI (AP) — From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines.
In the early '90s when South Africa's Themba Lethu clinic could only treat HIV/AIDS patients for opportunistic diseases, many would come in on wheelchairs and keep coming to the health center until they died.
There are no middle-aged people in Nyumbani. They all died years ago, before this village of hope in Kenya began. Only the young and old live here.
JOHANNESBURG (Reuters) – South Africa has achieved a "stunning" increase in life expectancy in the last three years due to a government push to roll out antiretroviral drugs (ARVs) to people with HIV/AIDS, researchers said on Thursday. The average South African is now likely to live to the age of 60, a study in the Lancet medical journal said, compared with just 56.5 in 2009 when President Jacob Zuma came to power with promises of a new approach to the country's HIV/AIDS burden. …
LONDON (Reuters) – A spiraling outbreak of HIV in debt-stricken Greece could run out of control if urgent action is not taken, European health officials said on Friday. The European Centre for Disease Prevention and Control (ECDC) said infections with the AIDS-causing virus among drug users and other high-risk groups were rising fast, and that a failure to act would mean far higher costs in future. …
LONDON (Reuters) – Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista for sale in Africa and other poor countries. U.S. healthcare group J&J said on Thursday it would not enforce patents, provided generic firms made high-quality versions of the drug – known generically as darunavir – for sub-Saharan Africa and Least Developed Countries. Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. …
In an ambitious road map for slashing the global spread of AIDS, the Obama administration says treating people sooner and more rapid expansion of other proven tools could help even the hardest-hit countries begin turning the tide of the epidemic over the next three to five years.
Wang Pinghe wants the tumor in his liver removed before it becomes life-threatening. But the 28-year-old Chinese villager knows it will be hard to find a hospital that will do the operation — because he has AIDS.
LONDON (Reuters) – Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson’s HIV/AIDS drug Prezista for sale in Africa and other poor countries. U.S. healthcare group J&J said on Thursday it would not enforce patents, provided generic firms made high-quality versions of the drug – known generically as darunavir – for sub-Saharan Africa and Least Developed Countries. Prezista is a relatively new drug used when patients develop resistance to older antiretrovirals. …
(Reuters) – Canada’s top court said on Friday that failing to tell a sexual partner you have HIV is only sexual assault if there is “a realistic possibility” of transmitting the virus that causes AIDS. In a unanimous decision, the Supreme Court of Canada rejected the government’s argument that everyone who has HIV should be required to disclose that condition to all sexual partners in any circumstance. …
South African and South Korean researchers are working on making a smartphone capable of doing AIDS tests in rural parts of Africa that are the worst hit by the disease, a researcher said Friday.